Karyopharm Therapeutics Inc. (KPTI)
NASDAQ: KPTI · Real-Time Price · USD
8.49
-0.28 (-3.19%)
At close: Mar 9, 2026, 4:00 PM EDT
8.33
-0.16 (-1.88%)
After-hours: Mar 9, 2026, 7:50 PM EDT
Karyopharm Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -196.04 | -76.42 | -143.1 | -165.29 | -124.09 | |
| Depreciation & Amortization | 0.3 | 0.34 | 0.53 | 0.62 | 0.79 | |
| Other Amortization | 10.55 | 6.37 | 0.81 | 0.81 | 0.78 | |
| Asset Writedown & Restructuring Costs | - | - | - | - | 7.36 | |
| Loss (Gain) From Sale of Investments | -0.41 | -2.5 | -4.1 | -0.83 | 1.56 | |
| Stock-Based Compensation | 14.05 | 18.43 | 21.71 | 35.4 | 29.78 | |
| Other Operating Activities | 67.92 | -73.39 | - | -0.28 | -0.11 | |
| Change in Accounts Receivable | 4.59 | -3.8 | 20.12 | -5.08 | -9.62 | |
| Change in Inventory | 0.7 | -1.7 | 1.18 | -0.12 | -1.46 | |
| Change in Accounts Payable | -1.1 | 1.98 | 0.35 | 1.17 | -2.85 | |
| Change in Other Net Operating Assets | 24.09 | 3.21 | 9.77 | -15.96 | -9.26 | |
| Operating Cash Flow | -75.37 | -127.49 | -92.72 | -149.55 | -107.12 | |
| Capital Expenditures | - | -0.14 | - | -0.12 | -0.21 | |
| Sale (Purchase) of Intangibles | - | - | - | - | -5.5 | |
| Investment in Securities | 43.38 | 95.62 | 7.94 | -104.14 | 147.55 | |
| Investing Cash Flow | 43.38 | 95.47 | 7.94 | -104.26 | 141.84 | |
| Long-Term Debt Issued | 27.25 | 83.3 | - | - | - | |
| Long-Term Debt Repaid | -0.25 | - | - | - | - | |
| Net Debt Issued (Repaid) | 27 | 83.3 | - | - | - | |
| Issuance of Common Stock | 9.51 | 1.45 | 1.12 | 193.74 | 13.65 | |
| Other Financing Activities | -6.46 | -43.11 | - | - | 60 | |
| Financing Cash Flow | 30.05 | 41.65 | 1.12 | 193.74 | 73.65 | |
| Foreign Exchange Rate Adjustments | 0.02 | -0.01 | -0.03 | -0.49 | -0.05 | |
| Net Cash Flow | -1.92 | 9.62 | -83.69 | -60.56 | 108.32 | |
| Free Cash Flow | -75.37 | -127.63 | -92.72 | -149.67 | -107.33 | |
| Free Cash Flow Margin | -51.60% | -87.88% | -63.50% | -95.29% | -51.15% | |
| Free Cash Flow Per Share | -6.89 | -15.10 | -12.18 | -27.42 | -21.40 | |
| Cash Interest Paid | 14.38 | 38.6 | 21.23 | 34.45 | 15.54 | |
| Levered Free Cash Flow | -49.43 | -77.09 | -39.95 | -101.35 | -58.64 | |
| Unlevered Free Cash Flow | -31.32 | -60.07 | -25.87 | -86.54 | -43.14 | |
| Change in Working Capital | 28.27 | -0.3 | 31.42 | -19.99 | -23.19 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.